Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Entresto
Pharma
Judge upholds MSN's generic Entresto nod amid Novartis challenge
As several generics circle the gates, Novartis has lost a bid to waylay MSN Pharmaceuticals’ copycat of the Swiss pharma’s top-selling drug Entresto.
Fraiser Kansteiner
Oct 17, 2024 2:59pm
Judge denies Novartis' bid to block generic Entresto launch
Aug 13, 2024 9:30am
Novartis doubles down in Entresto defense with FDA complaint
Aug 1, 2024 5:34pm
Novartis CEO sees IRA impact ‘manageable’ in short run
Jul 18, 2024 11:05am
Novartis gears up for key expansions of 3 cancer drugs
Apr 23, 2024 3:37pm
Novartis puts Kisqali's peak sales potential at above $7B
Nov 28, 2023 10:48am
